News & Insights

Oxford Technology & Innovations EIS Fund (OTIF) invests £230k into University of Oxford spinout company Oxford Endovascular Ltd

  • Oxford Endovascular Ltd is commercialising OxiFlow™, a novel blood flow diversion device (‘stent’) for treating Intracranial Aneurysms (ICAs).
  • OTIF’s investment was advised by Oxford Investment Consultants LLP and was part of a $10m Series A funding round led by Vulpes Investment Management, a Singapore-based life sciences investor.
  • This is the second OTIF investment in Oxford Endovascular to date, bringing total funds invested by the fund in the Company to £500k.
Read post